Company Filing History:
Years Active: 1992-1994
Title: Innovations of Joyce E Lawrence
Introduction
Joyce E Lawrence is a notable inventor based in Claremont, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents. With a total of 2 patents, her work focuses on improving treatments for serious medical conditions.
Latest Patents
One of her latest patents is for a viral-safe purified human thrombin. This invention describes a therapeutic grade thrombin that is essentially free of lipid envelope viruses. It boasts a specific activity ranging from about 2200 NIH units per milligram of protein to about 3200 NIH units per milligram of protein. The thrombin is homogeneous and can be produced on a commercial scale, making it suitable for human administration. Another significant patent involves pharmaceutical compositions and methods for the treatment or prophylaxis of sepsis. This invention includes compositions that contain a bactericidal effective amount of polyclonal immunoglobulins against Gram-negative bacteria and a blood clot-dissolving effective amount of protein C. The method for treatment may also include administering protein C cofactors and monoclonal antibodies against Gram-negative bacterial endotoxins.
Career Highlights
Joyce E Lawrence is currently associated with Baxter International Inc., a leading company in the healthcare sector. Her work at Baxter has allowed her to focus on innovative solutions that address critical health challenges.
Collaborations
Throughout her career, Joyce has collaborated with esteemed colleagues, including Michael J Griffith and Henry S Kingdon. These collaborations have further enhanced her research and development efforts.
Conclusion
Joyce E Lawrence's contributions to the field of pharmaceuticals demonstrate her commitment to innovation and improving patient care. Her patents reflect her expertise and dedication to addressing significant medical issues.